The nationwide wave of lawsuits against
opioid manufacturers, distributors, and retailers is, arguably, the most
significant litigation phenomenon of the 21st century. Opioid litigation
includes many features that are now familiar to observers of mass torts:
multi-district class-action litigation, government-entity plaintiffs, corporate
bankruptcy, and eye-popping settlements. This session will offer a brief
analysis of the current state of opioid litigation. Panelists and session
attendees will then share their views on the success of this litigation as a
response to the opioid crisis and discuss general lessons to be learned for the
future.
Business meeting at program conclusion.